Unicycive Therapeutics Inc. (UNCY) Statistics & Valuation Metrics - Stocknear

Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
4.36
0.04 (0.93%)
At close: Sep 05, 2025, 3:59 PM
4.25
-2.63%
After-hours: Sep 05, 2025, 06:49 PM EDT

Unicycive Therapeutics Statistics

Share Statistics

Unicycive Therapeutics has 12.77M shares outstanding. The number of shares has increased by 5.88% in one year.

12.77M
5.88%
5.86%
5.13%
11M
51
0.01%

Short Selling Information

The latest short interest is 1.22M, so 6.93% of the outstanding shares have been sold short.

1.22M
6.93%
7.2%
3.38

Valuation Ratios

The PE ratio is -14.48 and the forward PE ratio is 0.31. Unicycive Therapeutics's PEG ratio is 0.26.

-14.48
0.31
0
0.2
71.57
-18.57
0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Unicycive Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.1.

1.28
1.28
0.1
-0.02
-0.03
-452.35

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.67M
22
0
n/a

Taxes

-1.09M
2.89%

Stock Price Statistics

The stock price has increased by 22.38% in the last 52 weeks. The beta is 1.86, so Unicycive Therapeutics's price volatility has been higher than the market average.

1.86
22.38%
4.58
5.84
48.02
805,214

Income Statement

n/a
-428K
-32.12M
-36.73M
-36.23M
-36.66M
-0.56
Full Income Statement

Balance Sheet

The company has 26.14M in cash and 773K in debt, giving a net cash position of 25.37M.

26.14M
773K
25.37M
-101.27M
30M
15.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.57M and capital expenditures -72K, giving a free cash flow of -28.65M.

-28.57M
-72K
-28.65M
-0.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for UNCY is $60, which is 1288.9% higher than the current price. The consensus rating is "Buy".

$60
1288.9%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jun 20, 2025. It was a backward split with a ratio of 1:10.

Jun 20, 2025
backward
1:10

Scores

-6.46
1